Colon and Rectum Flashcards

1
Q

Describe Hirschsprungs disease

A
  • Absence of ganglion cells in Meissner’s and Auerbach’s plexus
  • Distal colon

Tissue sections show decreased ganglion cells and increased nerve fibers.

AKA Congenital aganglionic megacolon

  • Suspect when a newborn fails to pass meconium in first 24-48hrs.
  • 10% of all cases occur in Down syndrome

Physiology:

  • Absence of ganglion cells (likely) due to fsilure to migrate from vagal neural crest.
  • Unable to coordinate muscular activity
  • Causes spasticity of the affected bowel segment
  • Failure to coordinate peristaltic activity
  • Results in functional obstruction

Investigation:

  • Comfirm with full-thickness rectal biopsy
  • There is a naturally occuring hypoganglionic zone at sphincter site near muco-cutaneous junction - Not suitable to diagnose HD!!

Molecular:

  • RET gene mutation

Stains:

AChE stain (Acetylcholinesterase)
* Can only be done on frozen sections
* Increased number and thickness of AChE+ nerve fibres in stroma of lamina propria and muscularis mucosae

Calretinin
* Most widely used
* Absence of caslretinin staining in muscularis mucosae and lamina propria of aganglionic segment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe Amoebic Colitis

A
  • Entamoeba histolytica
  • Faeco-oral route
  • Sexual contact (oral-anal)
  • Seen in colon - Caecum is most common
  • Terminsl ileum ususally spared
  • Symptoms can range from mild diarrhoea (most common) to severe dysentery

Micro:
* Broad shaped ulcers
* Trophozoites resembles macrophages
* Seen at luminal surface/within debris

Investigation:
* Stool microscopy
* Nucleic acid amplification tests (NAATs)
* Serological testing for E. histolytica antibodies

Treatment:
* Invasive disease - Metronidazole or Tinidazole
* Luminal cysts - Paromomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe Intestinal Spirochaetosis

A
  • Brachyspira species

Micro:
* Maintained crypt architecture
* Accentuation, fuzziness and increased basophilia of the lumina surface
* Lamina propria –> mild to moderate lymphoplasmacytic inflammation

Stains
* Warthin-Starry
* Steiner
* Treponema pallidum immunohistochemistry

Treatment
* MEtronidazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe Pseudomembranous Colitis

A
  • Clostridium difficile (25%)
  • Clostridium perfringens
  • Staphylococcus Aureus
  • Presents as acute or chronic diarrhoea
  • May cause toxic megacolon and perforation

Risk factors:
* Antibiotics prior to onset
* Typically hospitalised
* Advanced age
* Immunosuppression

Investigation:
* C diff enterotoxin in stool

Macro:
* Hyperaemic mucosa with yellow-green exudate.

Micro:
* Denuded epithelium
* Mucopurulent exudate erupting out of crypts to form a mushroom-like cloud
* Karyorrhectic debris
* Neutrophils adhere to surface

Treatment:
* Vancomycin or metronidazole
* 25% may relapse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe Crohn’s Disease

A

Clinical:
* Onset 20-40 years
* Second peak 50-60 years
* Small bowel involvment (80%)
* Ileocolic involvement (30-40%)
* Transmural

Extraintestinal manifestations

Eyes: Episcleritis, Uveitis
Mouth: Stomatitis, Apthus ulcers
Liver: Steatosis
Biliary: Gallstones, Sclerosing cholangitis
Kidneys: Stones, fistulae
Skin: Erythema nodosum, Pyoderma gangrenosum
Joints: Spondylitis, Sacroilitis

Macro:
* Segmental involvement of the bowel
* Creeping fat –> transmural inflammation
* Thickened/Fibrotic bowel
* Strictures
* Mucosal apthous ulcers –> surrounded by hyperemia
* Cobblestone mucosa –> inflammatory pseudopolyps
* Fissures, sinus, fistulous tracts, abscesses

Micro:
* Skip lesions
* Apthous ulcers and deep fissuring ukcers
* Granulomas (only present in 50%)
* Lymphoid aggregates in subserosal adipose tissue
* Sinus tracks/fistula formation
* Dysplasia may be present in long-standing disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe Ulcerative Colitis

A

Clinical:
* Onset 15-30 years
* Second peak in 50-70 years
* Chronic active inflammation
* Starts in the rectum, proceeds prioximally
* Continuous diffuse pattern (pan-colitis)
* Changes limited to mucosa and superficial sub-mucosa
* Small bowel usually not involved, but…
* Can see mild inflammation in terminal ileum 20% (backwash ileitis)
* Toxic megacolon

Macro:
* Mucosal erythema
* Granularity, superficial ulceration
* Pseudopolyp formation - due to ulceration and intervening areas of preserved mucosa.
* Toxic megacolon - marked dilation and wall thinning

Micro:
* Crypt architecture distortion –> widespread crypt branching/atrophy/irregular spacing/shortening.
* Inflammatory expansion of lamina propria with basal lymphoplasmacytosis
* Neutrophilic inflammation with cryptitis/abscess

Activity:
* neutrophils
* abscesses
* ulceration

Chronicity
* architectural distortion
* inflammatory expansion of lamina propria
* paneth cell metaplasia or hyperplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Dysplasia in IBD

A

Inflammation –> DNA oxidative damage –> Cancer

  • Risk proportion to severity and duration of inflammation
  • Cancer risk in inflammatory bowel disease (2% risk)

Screening:

  • First 8-10 years after diagnosis –> no increased screening
  • Years 10-20 –> every 1-3 years (shorter if severe disease or PSC)
  • Years 20 and onwards –> 1-2 years

If indefinite for dysplasia:

  • Usually because of inflammation –> reactive vs dysplastic
  • Treat active disease
  • Repeat biopsy in 3-12 months

Intervention:

  • Resection endoscopically (if seen)
  • Needs meticulous colonoscopic follow up
  • Proctocolectomy –> if endoscopic resection not possible, non-visible HG dysplasia or adenoCa found.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe Ischaemic Colitis

A
  • Leading cause of acute abdomen in the elderly

Site:
* Watershed areas –> splenic flexure and rectosigmoid

Micro:
* Prominent hyalinization of lamina propria
* Haemorrhage
* Withered or atrophic crypts
* Surface epithelium my show regenerative changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Microscopic Colitis

A

Two Types:
* Lymphocytic colitis
* Collagenous colitis

Clinical:
* Cause of chronic non-bloody, watery diarrhoea
* Some are asymptomatic
* Associated with autoimmune disorders –> Thyroiditis, Coeliac disease, Diabetes, Psoriasis, Rheumatoid

  • Colon, Right > Left, Rectum
  • Females > Males

Causes:
* Idiopathic
* Viral infections
* Medications –> NSAIDS, Olmesartan, antidepressants

Lymphocytic Colitis:
* Colonic intraepithelial lymohocytosis (>20 per 100 enterocytes
* Diffuse increase in lamina propria inflammatory cells
* Preserved/Intact crypt architecture

Collagenous Colitis:
* Strong female predominance
* Strong association with certain medications –> NSAIDs, aspirin, PPI, H2 receptor agonists, SSRI

  • Subepithelial collagen band
  • Intraepithellial lymphocytosis
  • Mixed inflammation in the lamina propria
  • Surface mucosal damage
  • Preserved crypt architecture
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Diversion Colitis

A
  • AKA Defunctionalised bowel
  • Due to dietary deprivation of short chain fatty acids niormally produced by colonic bacteria
  • Mild colitis with crypt abscesses
  • Marked lymphoid hyperplasia –> initially in lamina propria, but later transmural

**Later in disease: **
* Muscularis mucosa hypertrophy
* Fatty and fibrous infiltration of submucosa
* Thickened muscularis propria and narrow lumen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Mucosal prolapse syndrome/Solitary rectal ulcer syndrome

A
  • Stupid name
  • Not always solitary, not always rectal, not always ulcerated, not really a syndrome
  • Solitary or multiple uklcerated or polypoid lesions
  • 4-10cm from anal margin
  • More common in women
  • Rare

Cause:
* Abnormal function of anal and pelvic floor musculature during defication
* Causes rectal mucosal prolapse or intussusception

Micro:
* Polypoid
* Crypt hyperplasia
* Cystic dilation
* Haphazardly arranged benign crypts
* Fibroblasts and smooth muscle proliferation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Angiodysplasia

A
  • Arteriovenous malformation
  • Angiodysplasia describes distinct GI mucosal vascular ectasias
  • Not associated with cutaneous lesions, systemic vascular disease or familial syndrome
  • Usually right colon
  • Can occur anywhere in small intestine or colon
  • Colon > Small intestine > Stomach

Clinical:
* Melena/bright red bloody stool
* May be associated with aortic stenosis or **von willebrand disease **

Micro:
* Numerous thin and thick walled dilated blood vessels
* Throughout the colonic submucosa and mucosa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

GVHD

A
  • Graft vs Host Disease
  • Complication of allogenic stem cell transplantation
  • T Cells from the donor recognise recipient tissue as foreign
  • Cytokine storm
  • Leads to organ damage

Site:
Skin > GI tract > Liver

Micro:
* Crypt apoptosis
* Crypt dropout
* Ulceration
* Inflammation tends to be sparse

Grading:

LERNER system

I: Crypt apoptosis without crypt dropout
II: Single crypt dropout
III: Contiguous crypt dropout
IV: Diffuse crypt dropout with ulceration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Conventional colorectal adenoma

A

Subtypes:
* Tubular adenoma
* Tubulovillous adenoma
* Villous adenoma

Risk of malignancy depends on:
* Higher number of lesions
* Larger Size –> 0.5% risk if <1cm, 10% risk if >2cm
* Higher proportion of villous architecture
* Extent of high-grade dysplasia

  • Polyps with HG dysplasia are pTis

Tubular –> 2-3% cancer risk
Tubulovillous –> 6-8% risk
Villous –> 18% risk

Molecular:

Chromosomal Instability Pathway (Most Common)
APC –> KRAS –> p53 (also beta catenin and SMAD4)

Lynch Microsatellite Instability Pathway
Germline MMR mutation –> Loss of heterozygosity –> Microsatellite instability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Tubular Adenoma

A
  • 80-85% of all adenomas
  • At least 75% tubular component
  • All tubular adenomas show dysplasia
  • More commonly in the left colon
  • When multiple (>10) —> may indicate FAP

Macro:
Small, round, pedunculated

Micro:
Round or oval glands

Molecular:
KRAS
P53
MGMT loss
APC
Beta Catenin

IHC:
BCL2
CEA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Tubulovillous and Villous Adenoma

A

Tubulo-villous adenoma

  • Mix of both tubulae and villous architecture
  • Villous architecture must compire at least 25% of the adenoma

Villous adenoma

  • Finger-like, leaflike epithelial fronds
  • Fronds contain vascular cores lined by dysplastic epithelium
  • Villous architecture comprises >75% adenoma
  • KRAS activation
  • tumour suppressor genes APC, SMAD4 and P53 inactivation

Villous and tubulovillous is associated with increased risk of colorectal neoplasia
16.8% versus 9.7% in tubular adenoma

17
Q

Serrated Polyps

A
  • Columnar cells with mucin depleted, eosiniphilic cytoplasm
  • May show dysplasia
  • Ectopic crypts
  • Contain either BRAF or KRAS mutation
  • BRAF-mutated MMR-deficient carcinoma
  • BRAF-mutated MMR-proficient carcinoma
  • KRAS-mutated MMR-proficient carcinoma
18
Q

Hyperplastic Polyp

A
  • Most common colonic polyp
  • Small, <10mm
  • Usually sessile
  • Usually left side of colon
  • Non significant potential for malignant degeneration

BRAF gene mutations –> Microvesicular variant
KRAS gene mutations –> Goblet cell rich variant

If found in the right side of colon… consider SSL

19
Q

Sessile Serrated Lesion

A
  • Premalignant lesion of the colorectum
  • Most frequently in right colon
  • Lesions >10mm or with HG dysplasia –>manage like high risk adenoma

Molecular:

  • BRAF (V600E) mutation
  • CpG island methylator phenotype (CIMP)
  • These lead to microsatellite instability due to promotor hypermethylation of MLH1

Micro:

  • Dilation/lateral spread of crypts at base of the lesion
  • Sawtooth appearance
20
Q

Traditional Serrated Adenoma

A
  • Least common
  • Neoplastic precursor lesion –> Aggressive BRAF mutated microsatellite instability (MSI) stable subtype of colorectal carcinoma
  • More often in rectosigmoid

Macro:
* Pedunculated
* Villiform architecture
* Resemble tubulovillous adenomas

Micro:
* Villiform architecture
* Columnar cells with abundant mucin-depleated eosinophillic cytoplasm
* Hypochromatic nuclei
* Minimal atypia
* Ectopic crypts

Treatment:
* Endoscopic removal of the adenoma

21
Q

Haggitt and Kikuchi Classifications

A

Haggitt Classification
* Depth of invasion in malignant **pedunculated **and sessile polyps
* Level 1: confined to head of polyp
* Level 2: at junction of head and stalk
* Level 3: confined to anywhere in the stalk
* Level 4: Invasion into the submucosa

Note: a sessile polyp has no stalk, so it automatically classified as Haggit level 4

Kikuchi Classification
* Depth of invasion into the submucosa of a malignant sessile polyp
* Sm1: upper 1/3 of submucosa
* Sm2: upper 2/3 of submucosa
* Sm3: lower 1/3 of submucosa

22
Q

What are the major hamartomatous polyposis syndromes

A
  • Juvenile polyposis syndrome
  • Peutz-Jeghers syndrome
  • Cowden disease
  • Bannayan-Riley-Ruvalcaba syndrome
  • Cronkite-Canada syndrome
23
Q

Juvenile Polyp

A
  • AKA retention polyps
  • 70% occur in children <10 years
  • Majority are solitary
  • Multiple may indicate a premalignant syndrome –> juvenile polyposis or juvenile polyposis syndrome

Prognosis:
* Extremely low risk of malignancy, unless syndromic
* Recurrence is common

Macro:
* Single pedunculated cherry-red polyps
* Smooth surface and contour

Micro:
* Surface shows ulceration and granulation tissue with regenerating epithelium
* Maybe mistaken for dysplasia
* Cystic spaces –> abundant mucin and inflammatory debris
* Glands are separated by expanded oedematous lamina propria containing inflammatory cells

Juvenile Polyposis Syndrome:
* 3-5 juvenile polyps in the colorectum OR
* Juvenile polyps throughout the GI tract OR
* Any number of juvenile polyps with a positive family history of juvenile polyposis

Autosomal dominant

Mutation:
* SMAD4
* BMPR1A

24
Q

Peutz-Jeghers Polyp/Syndrome

A

Autosomal dominant

Mutation:
* LKB1
* STK11
* On chromosome 19p
* Encodes serine/Threonine kinase

Clinical:
* Hamartomatous polyps throughout GI tract
* Small intestine > Colon > Stomach
* Mucocutaneous hyperpigmentation and macules on gentalia and palms/soles
* Marked increase in several malignancies –> Colon, Breast, Ovary, Cervix, Lung, Pancreas, Thyroid
* 1/3 of patients with sex cord tumor with annular tubules have Peutz-Jeghers syndrome.
* Almost all women with Peutz-Jeghers syndrome develop sex-cord tumor with annular tubules.
* Men may get calcifying sertoli cell tumors.

Micro:
* Complex glandular architecture
* Normal appearing epithelium
* Lamina propria with arbourising smooth muscle fascles
* Paneth cells may also be present
* Dysplasia is rare

25
Q

Cronkhite-Canada Syndrome

A

Non-Hereditary Syndrome
Currently considered idiopathic

  • Multiple polyps of the digestive tract
  • Anomalies of ectodermal tissues

GI manifestations:
* Polyps found in Stomach > Large intestine > Small intestine > Oesophagus
* Non-malignant
* Strawberry like

Other manifestations:
* Ectodermal tissues
* Alopecia
* Atrophy of nails
* Skin pigmentation

26
Q

Cowden syndrome/ Multiple Hamartoma syndrome

A

Autosomal dominant

Mutation:
* PTEN
* Tumour suppressor gene
* 10q22

Characterisation:
* Non-cancerous tunour like growths (hamartomas)
* Skin
* Mucous membranes –> mouth, nasal membranes, GI tract
* Thyroid
* Breast

At risk to certain forms of cancer:
* Breast carcinoma
* Thyroid carcinoma
* Endometrial carcinoma
* Kidney carcinoma

27
Q

Bannayan-Riley-Ruvalcaba Syndrome

A

Autosomal dominant

  • Overgrowth/hamartomatous disorder
  • Multiple subcutaneous lipomas
  • Macrocephaly
  • Haemangiomas
  • Dark penis freckles on penis

Mutation:
PTEN

28
Q

Adenomatous polyposis syndromes

A
  • Familial Adenomatous Polyposis (FAP)
  • Gardner’s
  • Turcot’s
  • Hereditary Nonpolyposis Colon Cancer HNPCC (Lynch’s Syndrome)
29
Q

FAP

A

Autosomal dominant
* 20-25 years of age
* 1% all colorectal cancers

  • Germline mutation
  • APC gene (5q21)
  • > 100 colorectal adenomatous polyps
  • Left colon/Rectum
  • Can develop fundic gland polyps and small intestinal polyps
  • 100% lifetime risk of colorectal adenoCa

Diagnostic Criteria:

  • 100 or more colorectal adenomatous polyps OR
  • Germline mutation in APC OR
  • Family Hx of FAP with colorectal adenomas (age <30)
  • Family Hx of FAP with at least one epidermoid cyst, osteoma or desmoid tumour

Variants

  • Gardner syndrome
  • Turcot syndrome
  • Attenuated familial adenomatous polyposis (AFAP)

AFAP –> fewer, more prox colonic distribution and later onset polyps and cancer

30
Q

Gardner’s Syndrome

A
  • Varient of FAP
  • Prominent extraintestinal manifestations

Extracolonic tumours:
* Osteomas of the skull
* Thyroid cancer
* Epidermoid cysts
* Fibromas
* Desmoid tumours

31
Q

Turcot’s Syndrome

A

Either:

  • **APC mutation **–> FAP and usually medulloblastoma

OR

  • MMR gene mutation –> Lynch syndrome with glioblastoma multiforme
32
Q

HNPCC

A
  • Autosomal dominant
  • 44 years onwards
  • 5% all colorectal cancers
  • Right colon
  • Mutation of DNA mismatch repair (MMR) gene
  • Most commonly germline mutation in MSH2 or MLH1
  • Less frequently due to MSH6 or PMS2

MLH1 partners with PMS2
MSH2 partners with MSH6.
Tumors that are MMR deficient have a better prognosis, are not prone to metastasis, and require less aggressive treatment.

MLH1 and MSH2 are the dominant partners, so if one of these is lost, it’s partner will be lost too.
If the non-dominant partner is lost, the dominant partner will remain.

It is much more likely to have the loss of one protein due to mutation than two proteins.

HNPCC Increased risk of cancers:

  • Endometrial carcinoma (33%)
  • Ovarian carcinoma (5%)
  • Small bowel
  • Stomach
  • Upper urinary tract
  • Brain

Muir Torre Syndrome –> Clinical variant

Diagnostic Criteria:
* Amsterdam
* Revised Bethesda Criteria

33
Q

Colon carcinoma

A

Risk factors:
* Older age
* Obesity
* Physical inactivity
* Alcohol
* IBD
* Schistosomiasis
* Family Hx

Polyposis Syndromes:
* FAP –> APC gene
* Lynch Syndrome –> MLH1, MSH2, MSH6, PMS2 genes
* Juvenile Polyposis –> SMAD4, PTEN genes
* Peutz-Jeghers Syndrome –> STK11 gene

Dietary risk factors:
* Low veg fibre
* High refined carbs
* Increased beef consumption
* Decreased vitamin A, C, E

Prognostic factors:
* Stage is most important prognostic factor
* Signet ring –> poorer prognosis
* Mucinous histology –> poorer prognosis
* Microsatellite instability better prognosis than stability

34
Q

Medullary AdenoCa

A
  • Usually right sided
  • High degree of microsatellite instability –> loss of normal DNA repair gene
  • Often better outcome independent of stage
  • 5-FU not as effective as with other MSI tumours

Micro:
* Sheets of poorly differentiated cells
* Pleomorphic

Molecular:
* Associated with MSI —> can be sporadic or Lynch Syndrome
* BRAF mutations common

Markers:
* CK7 +
* Calretinin +

  • CDX2 -ve
  • CD20 -ve
  • Weird for intestinal differentiation
35
Q

Mucinous AdenoCa

A
  • Usual Right sided
  • Same or worse prognosis than standard AdenoCa
  • Typically presents at more advanced stage
  • Greater nodal involvement than standard AdenoCa

Molecular:
* KRAS more common
* TP53 less common